Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.31 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4417021 | 0.97 | PIM1 (0.42) | PIM1KDM4EATMADRB2GAA | |
| SCHEMBL20061124 | 0.97 | PIM1 (0.42) | PIM1KDM4EATMADRB2GAA | |
| SCHEMBL13303583 | 0.97 | PIM1 (0.42) | PIM1KDM4EATMADRB2GAA | |
| Hydrochloric Acid SCHEMBL6656735 | 0.91 | PIM1 (0.40) | PIM1KDM4EADRB2GAAL3MBTL1 | |
| SCHEMBL9885359 | 0.86 | PIM1 (0.38) | PIM1KDM4EADRB2 | |
| SCHEMBL24316216 | 0.85 | ALDH1A1 (0.48) | PIM1KDM4EATMALDH1A1HSD17B10 | |
| SCHEMBL22647692 | 0.83 | PIM1 (0.34) | PIM1 | |
| SCHEMBL8905513 | 0.82 | CA1 (0.39) | PIM1KDM4EATMADRB2TAS1R3 | |
| SCHEMBL23970203 | 0.82 | CA1 (0.39) | PIM1KDM4EATMADRB2TAS1R3 | |
| SCHEMBL23970227 | 0.82 | CA1 (0.39) | PIM1KDM4EATMADRB2TAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11717803-B2 | Porous materials | UNIV LIVERPOOL (GB) | 2023-08-08 | — | — | US | disclosed |
| US-20200353439-A1 | POROUS MATERIALS | UNIV LIVERPOOL (GB) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11717803-B2 | Porous materials | SRM, CAPG, GRN | PIM1 1554/4885KDM4E 1120/4885ATM 163/4885 |
| US-20200353439-A1 | POROUS MATERIALS | SRM, CAPG, GRN | PIM1 1554/4885KDM4E 1120/4885ATM 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.